Business · 29/11/2016Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Information Collection for Abbreviated New Drug Applications and 505(b)(2) Applications
Summary
The U.S. Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information on Abbreviated New Drug Applications and 505(b)(2) Applications under the Paperwork Reduction Act of 1995
Original source language: Federal Register — Food and Drug AdministrationOpen original release →